|
| ||||||||||||||||||||||||||||||
| Latest Story |
| China Pharma Holdings, Inc. Announces Closing of $5.0 Million Registered Direct Offering |
| PR Newswire |
China Pharma Holdings, Inc. (NYSE American: CPHI) (the "Company"), a fully-integrated specialty pharmaceuticals company in China, today announced the closing of its previously announced registered direct offering of 2,500,000 shares of the Company's common stock, par value $0.001 per share, at a purchase price of $2.00 per share. The gross proceeds from the offering are $5 million, before deducting placement agent fees and other offering expenses. The Company intends to use the net proceeds from this offering for working capital and general corporate purposes. |
| Full Story → |
| Headline News |
| China Pharma Holdings, Inc. Announces Closing of $5.0 Million Registered Direct Offering |
| 12:33a ET July 24 '26 PR Newswire |
| China Pharma Announces Pricing of $5 Million Registered Direct Offering |
| 9:35a ET July 22 '26 PR Newswire |
| China Pharma Announces Pricing of $5 Million Registered Direct Offering |
| 9:32a ET July 22 '26 PR Newswire |
| More News → |
![]() | ||
|
| July 24 '26. Markets Closed. | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Previous data from yesterday, July 23 '26. | ||||||||||||||||||||||||||||||||||||||||||||||